Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.58% | -14.21% | -10.74% | -4.71% | 53.06% |
| Total Depreciation and Amortization | -9.37% | 5.96% | -1.46% | 69.14% | -17.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.52% | 130.57% | 24,466.67% | 161.17% | -95.39% |
| Change in Net Operating Assets | -1,827.21% | 56.40% | -109.73% | -125.99% | 108.39% |
| Cash from Operations | -12.62% | 18.97% | -81.98% | -403.85% | 2.85% |
| Capital Expenditure | -653.85% | 84.30% | -- | -- | 471.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -653.85% | 84.30% | -- | 7.98% | -98.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.02% | -51.40% | -- | -- | 417.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.52% | 96.52% | -- | -- | 176.81% |
| Cash from Financing | -69.16% | -83.32% | -- | -88.50% | 526.99% |
| Foreign Exchange rate Adjustments | 128.17% | -162.66% | 177.18% | 154.08% | -1,034.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.18% | -287.35% | -71.36% | -316.17% | 1,411.76% |